Comprehensive analysis of the status of drug resistance of Mycobacterium tuberculosis among different age group in China

Abstract

Abstract: Objective To analyze drug resistance of Mycobacterium tuberculosis in different age group in recent years,and to provide scientific evidence for further development of TB control poli-cy.Methods Systematic Review was applied to comprehensively analyze the status of drug resist- ance of Mycobacteriurn tuberculosis in different age group from 1996 to 2007.Results According to the systematic analysis of the literature in the past 10 years,the primary drug resistance rates were 28.0%,31.8% and 28.9% respectively in young group,middle age group and old group.There was significant difference between young group and middle age group(P<0.05),and there were no significant differences between young group and old group,middle age group and old group (P>0.05);the rates of acquired drug resistance were 70.1%,66.1% and 57.0% respectively in young group,middle age group and old group.There were significant differences among them(P<0.05). The frequency of primary drug resistance from high to low in order were S,R,H and E in young group and middle age group,and H,S,R and E in old group;the acquired drug resistance frequen- cy were H,R,S and E in all groups,the acquired resistance rate to H in young group was 71.0%, which was the highest among three groups.The rate of primary multi-drug resistance in middle age group was 4.2 %,higher than that in young group and old group,there were significant differences between young group and middle age group,middle age group and old group(P<0.05);the rate of acquired multi-drug resistance in young group was 45.2%,much higher than that in middle age group(35.2%)and old group(19.7%),there were significant differences among them(P<0.05).The rate that the drug resistance happens along with duration of medication is different a-mong different age group(P<0.05);the drug resistance rates in the group with 1～3 month of medication,the group with 4～6 month of medication and the group with more than 6 month of medication were 44.5%,66.8% and 83.1% respectively.There were significant differences among them(P<0.05),and the drug resistance happens fastest in the young group.Conclusions Prima- ry drug resistance or acquired drug resistance varies in different age groups with special characteris-tics,which is of important meaning to clarify the reason of drug resistance.It is suggested that great attention should be paid to tuberculosis cases in age group of high drug resistance.

Key words: Tuberculosis, Drug resistance,multiple, Systematic review

Fan Yongde¹,He Guangxue,Cheng Shiming,et al. Comprehensive analysis of the status of drug resistance of Mycobacterium tuberculosis among different age group in China[J]. Chinese Journal of Antituberculosis, 2008, 30(2): 85-89.

References

1 World Health Organization, Inlernational Union Against Tuber-culosis and Lung Disease. Anti tuberculosis drug resistance in the world： The WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance, Gxeneva：WHO/IUATLD, 1997：1-120
2 Word Health Organization. WHO/IUATLD Global Working Group on Antituberculosis Drug Resistance Surveillance Ciuide-lines for surveillance of drug resistance in tubercuiosis. Geneva：WHO,1997:216
3 Bloch AB,Cauthen GM，Onorato IM，et al. Nationwide survey of drug-revsistanl tuberculosis in the United States[J]. JAMA, 1994 ,27(1)： 665-671
4 唐神结，肖和平，夏祥新，等.不同年龄组结核分枝杆菌耐药性的研究[J].中华结核和呼吸杂志，2001,24(2)83-86
5 王国斌，彭义利，张国龙，等.河南省WHO结核病耐药监测报告[J].中国防痨杂志，1999,21(3)：167-168,(4) 185-190
6 杨晓明，路希伟.大连市结核病控制对策与结核病耐药趋势[J].中国防痨杂志，2003,25(4):219-222
7 沈秀萍，徐瑞兵，吕品.北京市西城区新发肺结核患者起始耐约性监测[J].中国防痨杂志，1999,21(1)：17-19
8 宋文虎.有关结核病耐药监测的几点看法[J].中华结核和呼吸杂志，2000,23(2)：73-74
9 屠德华.耐药性结核病的流行病学特征和意义[J].中华结核和呼吸杂志，1997，20(6)：208-211
10 王巍，姜平，李洪敏，等.结核病分枝杆菌耐药基因检测对获得性耐药性的研究[J].标记免疫分析与临床2004,11(4):219-222
11 王甦民，张福生，端木宏谨.山东省耐药结核病流行状况研究[J].中华结核和呼吸杂志，1999，22 ：7282-7301
12 廖光付，蓝红，许建荣，等.不同年龄复治肺结核忠齐结核分枝杆菌耐药性的研究[J].广西医学，2006,28(10)：1520-1522
13 钟球，钱明，李建伟.广东省WHO结核病耐药监测研究[J].中国防痨杂志，2001，23(1):5-8
14 王岗玲，李学玲，陈群，等.结核分枝杆菌1 293株的耐药性分析分析[J].职业与健康，2004,20(6):4143
15 李国明，吴兴荣，周丽平，等.湖北省结核分枝杆菌耐药性监测研究[J].中华结核和呼吸杂志，2002，25(12) ：723-726
16 李群，王晓萌，何海波，等.WHO浙江省结核病耐药监测研究报告[J].中华结核和呼吸杂志，2000,23(12) .718-721
17 郭文玉.孙咏棠.结核病原发耐药病例调查选例标准探讨[J].中国防痨杂志，1993,15 (2) ：72-73
18 陈裕，刘丽，吴宏君，等.郑州市1992-1996年结核分枝杆菌原发耐药性观察[J].中国防痨杂志，2001，23 (3) ：181-183

[1]	LIU Xiao-li, LEI Li-mei, GUO Zhou-li, HUANG Yin, XU Jing, ZHAO Xia, WANG Yan, FU Li. Study on the relationship of stigma and social support of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 1002-1008.
[2]	Academic Working Committee of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis . Expert consensus of clinical application of fixed-dose combination formulations [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 885-893.
[3]	JIN Hong-jian. The construction of tuberculosis prevention and control service system at county level in China needs to be strengthened urgently —— Comments and suggestions of an old tuberculosis control and prevention worker [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 896-902.
[4]	ZHANG Can-you, XIA Hui, CHENG Jun. Testing and reporting requirements for Class Ⅱ biosafety cabinet in tuberculosis laboratory [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 903-909.
[5]	ZHOU Lin, LIU Er-yong, MENG Qing-lin, CHEN Ming-ting, ZHOU Xin-hua, GAO Wei-wei, LIN Ming-gui, XIE Ru-ming. Evaluation of the quality of pulmonary tuberculosis diagnosis after the implementation of the newly revised WS 288-2017 Diagnosis for pulmonary tuberculosis standards [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 910-915.
[6]	LIU Er-yong, WANG Qian, ZHOU Lin, ZHANG Guo-qin, ZHANG Xiu-lei, MA Yong-cheng, YANG Shu-min, WANG Cui, MENG Qing-lin, CHEN Ming-ting, LIN Ming-gui, TU De-hua.. Analysis of diagnostic quality of pulmonary tuberculosis with negative etiology in some areas of China [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 916-920.
[7]	MENG Qing-lin, LI Jin-lan, LIN Ding-wen, MA Yong-cheng, HOU Shuang-yi, LIU Nian-qiang, ZHOU Lin. Analysis of the awareness about knowledge on the updated TB diagnosis standard among the practitioners in TB control institutions [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 921-925.
[8]	WANG Qian, ZHOU Lin, LIU Er-yong, ZHAO Yan-lin, LI Tao, CHEN Ming-ting, YANG Li-jia, WANG Jia.. A survey on the diagnostic ability of tuberculosis in the county-level medical institutions in China [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 926-930.
[9]	LI Ting, HE Jin-ge, SU Qian, LI Jing, LI Yun-kui, GAO Wen-feng, GAO Yuan, YANG Wen. Value of tuberculin test in screening tuberculosis infection in HIV infected/AIDS patients in Butuo County, Sichuan Province [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 931-936.
[10]	LI Yun-kui, HE Jin-ge, SU Qian, LI Ting, LI Jing, GAO Wen-feng, YANG Wen, MAO Guang-yu. Value of tuberculin test in screening tuberculosis infection in HIV infected/AIDS patients in Butuo County, Sichuan Province [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 937-941.
[11]	SU Qian, XIA Yong, LU Jia, WANG Dan-xia, HE Jin-ge. Analysis on the epidemiological characteristics of pulmonary tuberculosis among children aged 0-14 in Sichuan Province from 2009 to 2018 [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 942-947.
[12]	DENG Ya-li, ZHANG Tian-hua, LIU Wei-ping, ZHANG Hong-wei, MA Yu, LI Peng.. Temporal and spatial clustering analysis of pulmonary tuberculosis incidence in Shaanxi Province from 2014 to 2018 [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 948-955.
[13]	DONG Xiao, ZHAO Zhen, LIU Nian-qiang, WANG Sen-lu, CUI Yan. Analysis of the finding characteristics of pulmonary tuberculosis in the elderly population in Xinjiang Uygur Autonomous Region during 2009—2017 [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 956-961.
[14]	MA Ting-long, HAN Yi, CHENG Xu, LIU Zhi-dong. Clinical observation on treatment effectiveness of transdermal ultrasound-mediated drug delivery combined with oral anti-tuberculosis drug in patients with chest wall tuberculosis [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 968-972.
[15]	NAN Hai, ZHANG Yun, YANG Xin-ting, DUAN Hong-fei. Meta-analysis on the diagnostic value of GeneXpert MTB/RIF for bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 973-980.